Does LEFLUNOMIDE Cause Interstitial lung disease? 1,031 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,031 reports of Interstitial lung disease have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 1.8% of all adverse event reports for LEFLUNOMIDE.
1,031
Reports of Interstitial lung disease with LEFLUNOMIDE
1.8%
of all LEFLUNOMIDE reports
110
Deaths
301
Hospitalizations
How Dangerous Is Interstitial lung disease From LEFLUNOMIDE?
Of the 1,031 reports, 110 (10.7%) resulted in death, 301 (29.2%) required hospitalization, and 127 (12.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for LEFLUNOMIDE.
What Other Side Effects Does LEFLUNOMIDE Cause?
Drug ineffective (31,396)
Rheumatoid arthritis (20,886)
Pain (15,594)
Drug intolerance (14,142)
Joint swelling (13,026)
Fatigue (11,959)
Arthralgia (11,880)
Rash (11,239)
Contraindicated product administered (11,206)
Abdominal discomfort (10,333)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which LEFLUNOMIDE Alternatives Have Lower Interstitial lung disease Risk?
LEFLUNOMIDE vs LEMBOREXANT
LEFLUNOMIDE vs LENACAPAVIR
LEFLUNOMIDE vs LENALIDOMIDE
LEFLUNOMIDE vs LENIOLISIB
LEFLUNOMIDE vs LENOGRASTIM